SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-20-067754
Filing Date
2020-05-29
Accepted
2020-05-29 16:08:11
Documents
9
Period of Report
2020-05-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2021378d1_6k.htm 6-K 13462
2 EXHIBIT 99.1 tm2021378d1_ex99-1.htm EX-99.1 5500
3 EXHIBIT 99.2 tm2021378d1_ex99-2.htm EX-99.2 900
4 EXHIBIT 99.3 tm2021378d1_ex99-3.htm EX-99.3 9485
5 EXHIBIT 99.4 tm2021378d1_ex99-4.htm EX-99.4 9134
6 GRAPHIC tm2021378d1_ex99-1img001.jpg GRAPHIC 3889
7 GRAPHIC tm2021378d1_ex99-2img001.jpg GRAPHIC 219035
8 GRAPHIC tm2021378d1_ex99-3img001.jpg GRAPHIC 218792
9 GRAPHIC tm2021378d1_ex99-4img001.jpg GRAPHIC 219282
  Complete submission text file 0001104659-20-067754.txt   950334
Mailing Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000
Business Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000 4588773600
Zealand Pharma A/S (Filer) CIK: 0001674988 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38178 | Film No.: 20927749
SIC: 2834 Pharmaceutical Preparations